The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:

"
q2cbj1_9rhob like domain
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 5: Egl nine homolog 1

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 23 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
14 G5EBV0 (/IPI) Q62630 (/IPI) Q96KS0 (/IPI) Q96KS0 (/IPI) Q96KS0 (/IPI) Q96KS0 (/IPI) Q9GZT9 (/IPI) Q9GZT9 (/IPI) Q9H6Z9 (/IPI) Q9H6Z9 (/IPI)
(4 more)
Peptidyl-proline 4-dioxygenase activity GO:0031545
Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl trans-4-hydroxy-L-proline + succinate + CO2.
14 G5EBV0 (/IDA) Q6AYU4 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q9GZT9 (/IDA) Q9GZT9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA)
(4 more)
2-oxoglutarate-dependent dioxygenase activity GO:0016706
Catalysis of the reaction: A + 2-oxoglutarate + O2 = B + succinate + CO2. This is an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from 2-oxoglutarate and one other donor, and one atom of oxygen is incorporated into each donor.
12 Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q9GZT9 (/IDA) Q9GZT9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA)
(2 more)
Peptidyl-proline 4-dioxygenase activity GO:0031545
Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl trans-4-hydroxy-L-proline + succinate + CO2.
8 Q9GZT9 (/EXP) Q9GZT9 (/EXP) Q9H6Z9 (/EXP) Q9H6Z9 (/EXP) Q9H6Z9 (/EXP) Q9H6Z9 (/EXP) Q9H6Z9 (/EXP) Q9H6Z9 (/EXP)
Ferrous iron binding GO:0008198
Interacting selectively and non-covalently with ferrous iron, Fe(II).
6 Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q9GZT9 (/IDA) Q9GZT9 (/IDA)
Ferrous iron binding GO:0008198
Interacting selectively and non-covalently with ferrous iron, Fe(II).
5 P59722 (/ISS) Q6AYU4 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS) Q91YE3 (/ISS)
Peptidyl-proline dioxygenase activity GO:0031543
Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl hydroxy-L-proline + succinate + CO2.
5 P59722 (/IDA) Q8I0C2 (/IDA) Q8SX21 (/IDA) Q91UZ4 (/IDA) Q9VN98 (/IDA)
Peptidyl-proline 4-dioxygenase activity GO:0031545
Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl trans-4-hydroxy-L-proline + succinate + CO2.
5 Q8I0C2 (/ISS) Q8SX21 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS) Q9VN98 (/ISS)
Ferrous iron binding GO:0008198
Interacting selectively and non-covalently with ferrous iron, Fe(II).
4 Q96KS0 (/NAS) Q96KS0 (/NAS) Q96KS0 (/NAS) Q96KS0 (/NAS)
2-oxoglutarate-dependent dioxygenase activity GO:0016706
Catalysis of the reaction: A + 2-oxoglutarate + O2 = B + succinate + CO2. This is an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from 2-oxoglutarate and one other donor, and one atom of oxygen is incorporated into each donor.
4 Q91UZ4 (/ISO) Q91YE2 (/ISO) Q91YE2 (/ISO) Q91YE3 (/ISO)
2-oxoglutarate-dependent dioxygenase activity GO:0016706
Catalysis of the reaction: A + 2-oxoglutarate + O2 = B + succinate + CO2. This is an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from 2-oxoglutarate and one other donor, and one atom of oxygen is incorporated into each donor.
4 Q80X29 (/ISS) Q80X29 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS)
Oxygen sensor activity GO:0019826
Interacting selectively and non-covalently with and responding, e.g. by conformational change, to changes in the cellular level of oxygen (O2).
4 Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA)
Oxygen sensor activity GO:0019826
Interacting selectively and non-covalently with and responding, e.g. by conformational change, to changes in the cellular level of oxygen (O2).
4 Q80X29 (/ISS) Q80X29 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS)
Peptidyl-proline 4-dioxygenase activity GO:0031545
Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl trans-4-hydroxy-L-proline + succinate + CO2.
4 Q91UZ4 (/ISO) Q91YE2 (/ISO) Q91YE2 (/ISO) Q91YE3 (/ISO)
Iron ion binding GO:0005506
Interacting selectively and non-covalently with iron (Fe) ions.
3 Q8I0C2 (/ISM) Q8SX21 (/ISM) Q9VN98 (/ISM)
Ferrous iron binding GO:0008198
Interacting selectively and non-covalently with ferrous iron, Fe(II).
3 Q91YE2 (/ISO) Q91YE2 (/ISO) Q91YE3 (/ISO)
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
3 Q8I0C2 (/ISM) Q8SX21 (/ISM) Q9VN98 (/ISM)
Oxygen sensor activity GO:0019826
Interacting selectively and non-covalently with and responding, e.g. by conformational change, to changes in the cellular level of oxygen (O2).
2 Q91YE2 (/ISO) Q91YE2 (/ISO)
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
2 Q9GZT9 (/ISS) Q9GZT9 (/ISS)
Peptidyl-proline dioxygenase activity GO:0031543
Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl hydroxy-L-proline + succinate + CO2.
2 Q9GZT9 (/TAS) Q9GZT9 (/TAS)
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
1 P59722 (/IPI)
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
1 Q91YE3 (/ISO)
Peptidyl-proline dioxygenase activity GO:0031543
Catalysis of the reaction: peptidyl L-proline + 2-oxoglutarate + O2 = peptidyl hydroxy-L-proline + succinate + CO2.
1 Q91YE3 (/ISO)

There are 69 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Peptidyl-proline hydroxylation to 4-hydroxy-L-proline GO:0018401
The modification of peptidyl-proline to form 4-hydroxy-L-proline; catalyzed by procollagen-proline,2-oxoglutarate-4-dioxygenase.
14 G5EBV0 (/IDA) Q6AYU4 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q9GZT9 (/IDA) Q9GZT9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA)
(4 more)
Regulation of transcription from RNA polymerase II promoter in response to hypoxia GO:0061418
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
12 Q96KS0 (/TAS) Q96KS0 (/TAS) Q96KS0 (/TAS) Q96KS0 (/TAS) Q9GZT9 (/TAS) Q9GZT9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS)
(2 more)
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
10 Q62630 (/ISS) Q6AYU4 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS) Q9H6Z9 (/ISS) Q9H6Z9 (/ISS) Q9H6Z9 (/ISS) Q9H6Z9 (/ISS) Q9H6Z9 (/ISS) Q9H6Z9 (/ISS)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
7 P59722 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q9GZT9 (/IDA) Q9GZT9 (/IDA)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
6 Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP)
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
6 Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP)
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
6 Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP)
Protein hydroxylation GO:0018126
The addition of a hydroxy group to a protein amino acid.
6 Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA)
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
6 Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP) Q9H6Z9 (/IEP)
Peptidyl-proline hydroxylation to 4-hydroxy-L-proline GO:0018401
The modification of peptidyl-proline to form 4-hydroxy-L-proline; catalyzed by procollagen-proline,2-oxoglutarate-4-dioxygenase.
5 Q8I0C2 (/ISS) Q8SX21 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS) Q9VN98 (/ISS)
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
5 Q91UZ4 (/IMP) Q96KS0 (/IMP) Q96KS0 (/IMP) Q96KS0 (/IMP) Q96KS0 (/IMP)
Regulation of cell growth GO:0001558
Any process that modulates the frequency, rate, extent or direction of cell growth.
4 Q96KS0 (/NAS) Q96KS0 (/NAS) Q96KS0 (/NAS) Q96KS0 (/NAS)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
4 G5EBV0 (/IMP) Q8I0C2 (/IMP) Q8SX21 (/IMP) Q9VN98 (/IMP)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
4 Q80X29 (/ISS) Q80X29 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS)
Peptidyl-proline hydroxylation to 4-hydroxy-L-proline GO:0018401
The modification of peptidyl-proline to form 4-hydroxy-L-proline; catalyzed by procollagen-proline,2-oxoglutarate-4-dioxygenase.
4 Q91UZ4 (/ISO) Q91YE2 (/ISO) Q91YE2 (/ISO) Q91YE3 (/ISO)
Intracellular estrogen receptor signaling pathway GO:0030520
Any series of molecular signals generated as a consequence of an intracellular estrogen receptor binding to one of its physiological ligands. The pathway begins with receptor-ligand binding, and ends with regulation of a downstream cellular process (e.g. transcription).
4 Q96KS0 (/NAS) Q96KS0 (/NAS) Q96KS0 (/NAS) Q96KS0 (/NAS)
Cell redox homeostasis GO:0045454
Any process that maintains the redox environment of a cell or compartment within a cell.
4 Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA)
Cell redox homeostasis GO:0045454
Any process that maintains the redox environment of a cell or compartment within a cell.
4 Q80X29 (/ISS) Q80X29 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS)
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
4 Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
3 Q91YE2 (/ISO) Q91YE2 (/ISO) Q91YE3 (/ISO)
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
3 Q8I0C2 (/IMP) Q8SX21 (/IMP) Q9VN98 (/IMP)
Protein localization GO:0008104
Any process in which a protein is transported to, or maintained in, a specific location.
3 Q8I0C2 (/IMP) Q8SX21 (/IMP) Q9VN98 (/IMP)
Peptidyl-proline hydroxylation GO:0019511
The hydroxylation of peptidyl-proline to form peptidyl-hydroxyproline.
3 Q8I0C2 (/IDA) Q8SX21 (/IDA) Q9VN98 (/IDA)
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
3 Q8I0C2 (/IGI) Q8SX21 (/IGI) Q9VN98 (/IGI)
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
3 Q8I0C2 (/IMP) Q8SX21 (/IMP) Q9VN98 (/IMP)
Negative regulation of DNA-binding transcription factor activity GO:0043433
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
3 P59722 (/IDA) Q9GZT9 (/IDA) Q9GZT9 (/IDA)
Regulation of angiogenesis GO:0045765
Any process that modulates the frequency, rate or extent of angiogenesis.
3 P59722 (/ISS) Q9GZT9 (/ISS) Q9GZT9 (/ISS)
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
3 Q8I0C2 (/IMP) Q8SX21 (/IMP) Q9VN98 (/IMP)
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
2 Q62630 (/ISS) Q91UZ4 (/ISS)
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
2 Q62630 (/ISS) Q91UZ4 (/ISS)
Oxygen homeostasis GO:0032364
A homeostatic process involved in the maintenance of an internal steady state of oxygen within an organism or cell.
2 Q9GZT9 (/IDA) Q9GZT9 (/IDA)
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
2 Q62630 (/IMP) Q91UZ4 (/IMP)
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
2 Q91YE2 (/ISO) Q91YE2 (/ISO)
Cell redox homeostasis GO:0045454
Any process that maintains the redox environment of a cell or compartment within a cell.
2 Q91YE2 (/ISO) Q91YE2 (/ISO)
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
2 Q91YE2 (/ISO) Q91YE2 (/ISO)
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
2 Q91YE2 (/ISS) Q91YE2 (/ISS)
Negative regulation of cyclic-nucleotide phosphodiesterase activity GO:0051344
Any process that stops or reduces the rate of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate.
2 Q9GZT9 (/ISS) Q9GZT9 (/ISS)
Response to nitric oxide GO:0071731
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
2 Q9GZT9 (/IDA) Q9GZT9 (/IDA)
Response to nitric oxide GO:0071731
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
2 P59722 (/ISS) Q91YE3 (/ISS)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 G5EBV0 (/IGI)
Cellular iron ion homeostasis GO:0006879
Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
1 Q91YE3 (/IMP)
Terminal branching, open tracheal system GO:0007430
Formation of terminal branches in the open tracheal system. These are long cytoplasmic extensions that form fine tubules that transport oxygen directly to the tissues. An example of the process is found in Drosophila melanogaster.
1 Q8SX21 (/HMP)
Protein hydroxylation GO:0018126
The addition of a hydroxy group to a protein amino acid.
1 Q91UZ4 (/ISO)
Protein hydroxylation GO:0018126
The addition of a hydroxy group to a protein amino acid.
1 Q91UZ4 (/ISS)
Oxygen homeostasis GO:0032364
A homeostatic process involved in the maintenance of an internal steady state of oxygen within an organism or cell.
1 Q91YE3 (/ISO)
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
1 Q91UZ4 (/ISO)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
1 P59722 (/IDA)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
1 Q91YE3 (/ISO)
Negative regulation of DNA-binding transcription factor activity GO:0043433
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
1 Q91YE3 (/ISO)
Regulation of angiogenesis GO:0045765
Any process that modulates the frequency, rate or extent of angiogenesis.
1 Q91YE3 (/IMP)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
1 Q91YE3 (/IMP)
Negative regulation of cyclic-nucleotide phosphodiesterase activity GO:0051344
Any process that stops or reduces the rate of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate.
1 P59722 (/IDA)
Negative regulation of cyclic-nucleotide phosphodiesterase activity GO:0051344
Any process that stops or reduces the rate of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate.
1 P59722 (/IMP)
Negative regulation of cyclic-nucleotide phosphodiesterase activity GO:0051344
Any process that stops or reduces the rate of cyclic nucleotide phosphodiesterase activity, the catalysis of the reaction: nucleotide 3',5'-cyclic phosphate + H2O = nucleotide 5'-phosphate.
1 Q91YE3 (/ISO)
Cardiac muscle tissue morphogenesis GO:0055008
The process in which the anatomical structures of cardiac muscle tissue are generated and organized.
1 Q91YE3 (/IMP)
Heart trabecula formation GO:0060347
The process of creating a trabecula in the heart. A trabecula is a tissue element in the form of a small beam, strut or rod.
1 Q91YE3 (/IMP)
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
1 Q91YE3 (/IMP)
Labyrinthine layer development GO:0060711
The process in which the labyrinthine layer of the placenta progresses, from its formation to its mature state.
1 Q91YE3 (/IMP)
Response to nitric oxide GO:0071731
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus.
1 Q91YE3 (/ISO)
Regulation of postsynapse organization GO:0099175
Any process that modulates the physical form of a postsynapse.
1 Q91YE3 (/IDA)
Regulation of postsynapse organization GO:0099175
Any process that modulates the physical form of a postsynapse.
1 Q91YE3 (/IMP)
Regulation of protein catabolic process at postsynapse, modulating synaptic transmission GO:0099576
Any process that modulates synaptic transmission by regulating a catabolic process occurring at a postsynapse.
1 Q91YE3 (/IDA)
Regulation of protein catabolic process at postsynapse, modulating synaptic transmission GO:0099576
Any process that modulates synaptic transmission by regulating a catabolic process occurring at a postsynapse.
1 Q91YE3 (/IMP)
Regulation of neuron death GO:1901214
Any process that modulates the frequency, rate or extent of neuron death.
1 Q91YE3 (/IMP)
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
1 P59722 (/IDA)
Positive regulation of neuron death GO:1901216
Any process that activates or increases the frequency, rate or extent of neuron death.
1 Q91YE3 (/ISO)
Negative regulation of CAMKK-AMPK signaling cascade GO:1905290
Any process that stops, prevents or reduces the frequency, rate or extent of CAMKK-AMPK signaling cascade.
1 P59722 (/IMP)
Negative regulation of CAMKK-AMPK signaling cascade GO:1905290
Any process that stops, prevents or reduces the frequency, rate or extent of CAMKK-AMPK signaling cascade.
1 Q91YE3 (/ISO)
Cellular response to leukemia inhibitory factor GO:1990830
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
1 Q91UZ4 (/IEP)

There are 16 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
11 G5EBV0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA)
(1 more)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
11 A0A024R0R2 (/IDA) A0A024R0R2 (/IDA) A0A024R0R2 (/IDA) A0A024R0R2 (/IDA) Q8I0C2 (/IDA) Q8SX21 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA) Q96KS0 (/IDA)
(1 more)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
11 P59722 (/IDA) Q9GZT9 (/IDA) Q9GZT9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) R4SCQ0 (/IDA)
(1 more)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
10 Q96KS0 (/TAS) Q96KS0 (/TAS) Q96KS0 (/TAS) Q96KS0 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
8 Q9GZT9 (/IDA) Q9GZT9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA) Q9H6Z9 (/IDA)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
8 Q9GZT9 (/TAS) Q9GZT9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS) Q9H6Z9 (/TAS)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
7 Q62630 (/ISS) Q6AYU4 (/ISS) Q80X29 (/ISS) Q80X29 (/ISS) Q91UZ4 (/ISS) Q91YE2 (/ISS) Q91YE2 (/ISS)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
3 Q91UZ4 (/ISO) Q91YE2 (/ISO) Q91YE2 (/ISO)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
2 Q91YE2 (/ISO) Q91YE2 (/ISO)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
2 Q91UZ4 (/ISO) Q91YE3 (/ISO)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
2 Q62630 (/ISS) Q91UZ4 (/ISS)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
2 Q91UZ4 (/ISO) Q91YE3 (/ISO)
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
1 Q91YE3 (/IDA)
Dendrite GO:0030425
A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
1 G5EBV0 (/IDA)
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
1 Q91YE3 (/IDA)
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
1 Q91YE3 (/IMP)
CATH-Gene3D is a Global Biodata Core Resource Learn more...